Reuters logo
BRIEF-Corvus Pharmaceuticals and Monash University enter into exclusive license agreement
May 9, 2017 / 12:38 PM / 6 months ago

BRIEF-Corvus Pharmaceuticals and Monash University enter into exclusive license agreement

May 9 (Reuters) - Corvus Pharmaceuticals Inc:

* Corvus Pharmaceuticals and Monash University enter into exclusive license agreement for novel immuno-oncology program

* Corvus Pharmaceuticals - licensed global rights to undisclosed novel immuno-oncology program, which includes lead product candidate, from Monash University Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below